Henry H. Balfour, Jr., M.D.

Professor
Medical Director, Clinical Virology Laboratory
612-626-5670
balfo001@umn.edu

Dr. Balfour’s primary staff appointment is at University of Minnesota Medical Center, Fairview, where he instructs residents in the virology section of the microbiology rotation. 

Educational Background

• Columbia University (1966), M.D.
• University of Minnesota (1968), Internship (Pediatrics)
• Columbia Babies Hospital (1969), Residency (Pediatrics)
• University of Minnesota (1972), Fellowship (Pediatric Infectious Disease)

Board Certification

Pediatrics

Research Interests

• Principal Investigator, University of Minnesota AIDS Clinical Trials Unit (NIH)
• Co-investigator, Minnesota AIDS Clinical Trials Unit Advanced Technology HIV laboratory
• Co-investigator, Great Lakes Center for AIDS Research (AFAR, an NIH-sponsored consortium with Northwestern University, University of Wisconsin and University of Michigan)
• Director, International Center for Antiviral Research and Epidemiology
• Project Director, collaborative research on concentration-controlled antiretroviral therapy for the management of HIV disease

Professional Memberships

• Editorial Board of the International Journal of Antimicrobial Agents
• Scientific Advisory Board of the Varicella-Zoster Virus Research Foundation
• Infection Control Committee
• Advisory Board for Emerging Pathogens Program of the Minnesota Department of Health

Publications

Dr. Balfour has written extensively on a number of virology topics, including antiviral combination drug therapy protocols for HIV. He is an ad hoc reviewer for seven scientific journals. 

• Cavert W, Webb C-H, Balfour HH Jr.  Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy. J Infect Dis 2004;189:2181-4.